Advanz Pharma Corp (ADVZ)

Toronto

Currency in CAD

6.20

0.00(0.00%)

Closed27/03

Fair Value

Day's Range

6.04

7.45

52 wk Range

0.00

7.45

ADVZ Income Statement

Featured here, the Income Statement (earnings report) for Advanz Pharma Corp, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2013

31/12

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

Total Revenues

536.99

508.32

525.58

Total Revenues Growth

-14.24%

-5.34%

+3.4%

Cost Of Revenues

175.89

171.51

188.41

Gross Profit

361.1

336.81

337.18

Gross Profit Growth

-17.15%

-6.73%

+0.11%

Gross Profit Margin %

67.25%

66.26%

64.15%

Other Operating Expenses, Total

365.44

313.72

303.48

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+2.21%	-14.15%	-3.27%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	29.71	29.12	33.05
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	83.63	78.05	74.88
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-

Operating Income

-4.35

23.09

33.7

Operating Income Growth

-105.55%

+631.37%

+45.97%

EBIT Margin %

-0.81%

4.54%

6.41%

Net Interest Expenses

-255.43

-103.49

-99.62

Net Interest Expenses Growth

+42.66%

+59.48%

+3.74%

Interest Expense, Total

-257.66

-105.68

-100.58

Interest And Investment Income

2.23

2.2

0.96

Other Non Operating Expenses, Total

-44.36

25.5

-18.84

EBT, Excl. Unusual Items

-304.13

-54.9

-84.75

Gain (Loss) On Sale Of Assets

-

-

-

Other Unusual Items, Total

1,772.87

-122.08

-8.36

EBT, Incl. Unusual Items

1,468.74

-218.03

-123.77

EBT, Incl. Unusual Items Growth

+190.25%

-114.84%

+43.23%

EBT, Incl. Unusual Items Margin

273.52%

-42.89%

-23.55%

Income Tax Expense

1.44

-22.01

-48.91

Net Income to Company

1,467.3

-196.02

-74.86

Minority Interest

-

-

-

Net Income

1,467.3

-196.02

-74.86

Net Income Growth

+192.24%

-113.36%

+61.81%

Net Income Margin %

273.25%

-38.56%

-14.24%

Preferred Dividend and Other Adjustments

-

-

-

Net Income to Common Excl. Extra Items

1,467.3

-196.02

-74.86

Basic EPS - Continuing Operations

93.69

-4.01

-1.53

Basic EPS - Continuing Operations Growth

+101%

-104.28%

+61.81%

Diluted EPS - Continuing Operations

93.69

-4.01

-1.53

Diluted EPS - Continuing Operations Growth

+101%

-104.28%

+61.84%

Basic Weighted Average Shares Outstanding

15.66

48.91

48.91

Diluted Weighted Average Shares Outstanding

15.66

48.91

48.91

Dividend Per Share

-

-

-

Dividend Per Share Growth

-

-

-

EBITDA

247.76

229.64

229.25

EBITDA Growth

-19.22%

-7.31%

-0.17%

EBITDA Margin %

46.14%

45.18%

43.62%

EBIT

-4.35

23.09

33.7

* In Millions of USD (except for per share items)

South Africa Top 40

78,378.41

+666.75

+0.86%

S. Africa 40 Futures

78,573.00

+614

+0.79%

45,003.80

-10.2

-0.02%

6,082.70

-3.8

-0.06%

21,461.50

-28.2

-0.13%

20,344.00

+91.0

+0.45%

106.197